Venrock Healthcare Capital Partners II L.P. 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 6:04 pm Sale | 2025-06-30 | 13G | Cogent Biosciences, Inc. COGT | Venrock Healthcare Capital Partners II L.P. | 4,755,411 4.200% | -1,691,506 (-26.24%) | Filing |
| 2025-04-11 6:28 pm Purchase | 2024-09-30 | 13G | Cogent Biosciences, Inc. COGT | Venrock Healthcare Capital Partners II L.P. | 6,446,917 5.800% | 6,446,917 (New Position) | Filing |
| 2022-02-14 4:14 pm Sale | 2021-12-31 | 13G | Cogent Biosciences, Inc. COGT | Venrock Healthcare Capital Partners II L.P. | 4,302,126 9.990% | -53,147 (-1.22%) | Filing |